Companies People   

Home / Companies / Industries / Biotechnology and Drugs / SIGA Technologies, Inc. Overview


SIGA Technologies, Inc. Overview

State:New York
Country:United States
Industry:Biotechnology and Drugs
Description:
SIGA Technologies, Inc. (SIGA), incorporated on December 28, 1995, is engaged in the research, development and commercialization of products for the prevention and treatment of serious infectious diseases, including products for use in defense against biological warfare agents, such as smallpox and Arenaviruses. Its product, ST-246, is an orally administered antiviral drug that targets orthopox viruses. Its antiviral programs are designed to prevent or limit the replication of the viral pathogen. For the fiscal year ended 31 December 2009, SIGA... (More)










Get Trial Access to OneSource

Company profiles, executive contacts, industry research, and news for sales, marketing and research professionals.

Please Enter a Valid Business Email



Disclaimer: While the OneSource Subscription Service maintains the freshest, most accurate data possible, this free site is refreshed on a periodic basis and may occasionally contain information that is not current. If you would like to alert us to a change, please email us, and we will take steps to make sure your update is included as soon as possible